Business
Notice of results and investor briefing
Notice of results and investor briefing.
About this update from Creo Medical Group Plc
[{"type":"text","content":"\n \nRNS Number : 4892T Creo Medical Group PLC 21 March 2019 \n\n \n Creo Medical Group plc\n(\"Creo\" or the \"Company\")\n \nNotice of results and investor briefing\n \nCreo Medical Group plc (AIM: CREO), a medical device company focused on the emerging field of surgical endoscopy, will announce its final results for the 18 month period to 31 December 2018 on Friday 5 April 2019.\n \nInvestor briefing\nA briefing for investors will take place on Tuesday 9 April 2019 at the Brand Exchange, 3 Birchin Lane, EC3V 9BW at 5.15pm for a 5.30pm start and will be followed by refreshments. If you would like to register, please contact Walbrook PR on 020 7933 8780 or email [email protected]\n \n- Ends -\n \nFor further information please contact:\n \n\n\n\n\nCreo Medical Group plc\n\n\n \n\n\n\n\nRichard Rees (CFO)\n\n\n+44 (0)129 160 6005 \n\n\n\n\n \n\n\n \n\n\n\n\nCenkos Securities\n\n\n+44 (0)20 7397 8900\n\n\n\n\nStephen Keys / Mark Connelly (NOMAD)\n\n\n \n\n\n\n\nMichael Johnson / Russell Kerr (Sales)\n\n\n \n\n\n\n\n \n\n\n \n\n\n\n\nWalbrook PR Ltd\n\n\nTel: +44 (0)20 7933 8780 or [email protected]\n\n\n\n\nPaul McManus\n\n\nMob: +44 (0)7980 541 893\n\n\n\n\nHelen Cresswell\n\n\nMob: +44 (0)7841 917 679\n\n\n\n\n \nAbout Creo Medical\n \nCreo Medical, founded in 2003, is a medical device company focused on the development and commercialisation of minimally invasive surgical devices, by bringing advanced energy to endoscopy. The Company's mission is to improve patient outcomes by applying microwave and RF energy to surgical endoscopy. Creo has developed CROMA, an electrosurgical advanced energy platform that combines bipolar radiofrequency for precise localised cutting and microwave for controlled coagulation. This technology provides clinicians with flexible, accurate and controlled surgical solutions.\n \nThe Company's strategy is to bring its CROMA platform to market through a su...